Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com CN

CD86

Catalog Number:OM629693
OM629693
Discount Price
OM629693-100ul
1~2 Week
100ul
OM629693-50ul
50ul
OM629693-20ul
20ul
1~2 Week
Product Profile
Product Name CD86
Antibody Type Primary Antibodies
Product description

Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation.

Immunogen KLH conjugated synthetic peptide derived from the middle of human CD86 140-175/313
Key Feature
Clonality Polyclonal
Isotype IgG
Host Species Rabbit
Tested Applications FCICC/IFIHC-PWB
WB:1:500-2000:
IHC-P:1:400-800:
FC:1μg/Test:
IF:1:100-500:
ICC:1:100-500:
Species Reactivity CowDogHumanMousePigRatSheep
Concentration 1mg/ml
Target Information
Alternative Names CD28LG2 FUN1 LAB72 Activation B7 2 antigen Activation B7-2 antigen 3 CD86_HUMAN Activation B7-2 antigen Activation B72 antigen B lymphocyte activation antigen B7 2 B lymphocyte activation antigen B72 B-lymphocyte activation antigen B7-2 2 B-lymphocyte activation antigen B7-2 B7 2 B7 2 antigen B7 B7-2 B7.2 B70 B72 antigen BU63 CD 86 CD28 antigen ligand 2 2 CD28 antigen ligand 2 Cd28l2 CD28LG2 CD86 antigen (CD28 antigen ligand 2
B7-2 antigen) 1
2 CD86 antigen CD86 molecule CLS1 CTLA 4 counter receptor B7 2 CTLA 4 counter receptor B7.2 CTLA-4 counter-receptor B7.2 2
3 CTLA4 counter receptor B72 Early T-cell costimulatory molecule 1 ETC-1 FUN 1 LAB72 Ly-58 Ly58 MB7 MB7-2 Membrane glycoprotein MGC34413 T lymphocyte activation antigen CD86 T-lymphocyte activation antigen CD86 TS/A-2.
Molecular Weight(MW) 31 KDa
Cellular Localization Cell membrane; Single-pass type I membrane protein.
Database Links
SwissProt ID O35531
Application

Application

Fig1: Tissue/cell: BV-2 cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum, C-0005) at 37℃ for 20 min; Antibody incubation with (CD86) Polyclonal Antibody, Unconjugated (ER1906-01) 1:200, 90 minutes at 37℃; followed by a conjugated Goat Anti-Rabbit IgG antibody (bs-0295G-FITC) at 37℃ for 90 minutes, DAPI (5ug/ml, blue, C-0033) was used to stain the cell nuclei.

Application

Fig2: Sample: Lymph node(Mouse)Cell Lysate at 40 ug Primary: Anti-CD86 (ER1906-01) at 1/300 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 31 kD Observed band size: 31 kD

Application

Fig3: Tissue/cell: rat lung tissue; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min; Incubation: Anti-CD86/B7-2 Polyclonal Antibody, Unconjugated(ER1906-01) 1:200, overnight at 4℃, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining

Application

Fig4: Sample: Brain(Rat) lysates at 30ug; Heart(Rat) lysates, 30ug; Primary: Anti-CD86/B7-2 (ER1906-01) at 1:200; Secondary: HRP conjugated Goat Anti-Rabbit IgG(bs-0295G-HRP) at 1: 3000; ECL excitated the fluorescence; Predicted band size : 34kD Observed band size : 34kD

Application

Fig5: Blank control: U937(blue). Primary Antibody: Rabbit Anti-CD86 antibody(ER1906-01), Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA; Isotype Control Antibody: Rabbit IgG (orange) ,used under the same conditions. Secondary Antibody: Goat anti-rabbit IgG-PE(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA. Protocol The cells were fixed with 2% paraformaldehyde (10 min).Primary antibody (ER1906-01, 1μg /1x10^6 cells) were incubated for 30 min on the ice, followed by 1 X PBS containing 0.5% BSA + 10% goat serum (15 min) to block non-specific protein-protein interactions. Then the Goat Anti-rabbit IgG/PE antibody was added into the blocking buffer mentioned above to react with the primary antibody at 1/200 dilution for 30 min on ice. Acquisition of 20,000 events was performed.

WB

(a–c) Representative western blot bands and analysis of CD86 and CD206 around the lesion area (n = 6).

WB

(a–c) Representative western blot bands and analysis of CD86 and CD206 around the lesion area (n = 6).

WB

(a–c) Representative western blot bands and analysis of CD86 and CD206 around the lesion area (n = 6).

IF

(d and f) Immunofluorescence of CD86+/CD11b+ and CD206+/CD11b+ cells in the lesion area (n = 3, each sample was calculated from two separate fields of view).

IF

(d and f) Immunofluorescence of CD86+/CD11b+ and CD206+/CD11b+ cells in the lesion area (n = 3, each sample was calculated from two separate fields of view).
Positive Control Expressed by activated B-lymphocytes and monocytes.
Application Notes WB:1:500-2000:
IHC-P:1:400-800:
FC:1μg/Test:
IF:1:100-500:
ICC:1:100-500:
Additional Information
Form Liquid
Storage Instructions Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.
Storage Buffer 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
validation
question title
question detaiil
Verification code
 

References(1)